Searchable abstracts of presentations at key conferences in endocrinology

ea0050oc4.5 | Adrenal and Steroids | SFEBES2017

NAD+ availability modulates 11β-HSD1 mediated glucocorticoid regeneration in mouse skeletal muscle

Elhassan Yasir , Fletcher Rachel , Cartwright David , Oakey Lucy , Garten Antje , Doig Craig , Lavery Gareth

11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is an NADPH-dependant oxo-reductase located in the sarcoplasmic reticulum (SR) lumen of skeletal muscle. It generates active glucocorticoids to regulate permissive and adaptive metabolism. Hexose-6-phosphate dehydrogenase (H6PD) interacts with 11β-HSD1 to generate an appropriate NADPH/NADP+ ratio to support activity. H6PD depletion impairs SR NADPH generation triggering 11β-HSD1 to assume glucocorticoid ina...

ea0050oc4.3 | Adrenal and Steroids | SFEBES2017

Local reactivation of glucocorticoids by 11β-HSD1 mediates their detrimental effects on bone

Fenton Chloe , Doig Craig , Raza Karim , Cooper Mark , Lavery Gareth , Hardy Rowan

Glucocorticoids (GCs) have potent immunomodulatory and anti-inflammatory effects and are widely used in the treatment of inflammatory diseases. Unfortunately, their long term administration causes serious systemic metabolic side effects including osteoporosis, muscle wasting and insulin resistance. 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is responsible for the local conversion of inactive GCs to their active counterparts. It has been shown that many of the...

ea0050oc4.5 | Adrenal and Steroids | SFEBES2017

NAD+ availability modulates 11β-HSD1 mediated glucocorticoid regeneration in mouse skeletal muscle

Elhassan Yasir , Fletcher Rachel , Cartwright David , Oakey Lucy , Garten Antje , Doig Craig , Lavery Gareth

11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is an NADPH-dependant oxo-reductase located in the sarcoplasmic reticulum (SR) lumen of skeletal muscle. It generates active glucocorticoids to regulate permissive and adaptive metabolism. Hexose-6-phosphate dehydrogenase (H6PD) interacts with 11β-HSD1 to generate an appropriate NADPH/NADP+ ratio to support activity. H6PD depletion impairs SR NADPH generation triggering 11β-HSD1 to assume glucocorticoid ina...

ea0086p155 | Adrenal and Cardiovascular | SFEBES2022

Glucocorticoid Excess Disrupts the NAD+ Metabolome Within Skeletal Muscle in Male and Female C57BL/6J Mice

Heising Silke , Heaselgrave Samuel , Morgan Stuart , Kabli Ali , Doig Craig , Tsintzas Kostas , Lavery Gareth

Introduction: Glucocorticoid excess (GE) causes severe metabolic dysfunction within skeletal muscle (SM) which includes reduced muscle accrual and increased proteolysis. The NAD+ metabolome is crucial for SM health and metabolic function, however, whether this is disrupted by GE remains unknown.Methods: Male and female C57BL/6J mice (n=12) were treated with a vehicle control or corticosterone (100 mg/l) ad libitum via drinking water for 3 weeks ...

ea0044oc4.2 | Adrenal and Steroids | SFEBES2016

Nicotinamide riboside and cellular NAD+ redox state influence 11β-HSD1 mediated glucocorticoid regeneration in skeletal muscle cells

Elhassan Yasir , Fletcher Rachel , Oldacre-Bartley Lucy , Doig Craig , Lavery Gareth

11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is an NADPH-dependant oxo-reductase located in the sarcoplasmic reticulum (SR) lumen of skeletal muscle. Here it generates active glucocorticoids to regulate permissive and adaptive metabolism, and can mediate the pathological effects of glucocorticoid excess. Hexose-6-phosphate dehydrogenase (H6PD) in the SR interacts with 11β-HSD1 to generate an appropriate NADPH/NADP+ ratio to support activity. H6PD depletion...

ea0044p189 | Obesity and Metabolism | SFEBES2016

Mechanisms of ageing metabolic decline revealed by targeted metabolomics and energy metabolism in NAD+ depleted skeletal muscle

Fletcher Rachel , Oldacre-Bartley Lucy , Doig Craig , Brenner Charles , Lavery Gareth

Nicotinamide adenine dinucleotide (NAD+) levels increase during metabolic stress, which acts as a consumed substrate by, amongst other proteins, the sirtuins, which adapt transcriptional programmes to increase energy availability and regulate insulin sensitivity. Thus, maintaining appropriate skeletal muscle NAD+ availability is critical for regulating systemic energy homeostasis. In order to gain better insight into ageing muscle NAD+ dynamics we used ta...

ea0041oc2.5 | Receptors & Signalling | ECE2016

11β-HSD1 is a regulator of brown adipose tissue function and mediates stress adaptation in glucocorticoid excess

Doig Craig , Morgan Stuart , Philp Andrew , Tomlinson Jeremy , Stewart Paul , Lavery Gareth

Glucocorticoids (GC) are critical to stress adaptation but in excess (Cushing’s syndrome) drive metabolic dysfunction. 11β-hydroxysteroid dehydrogenase type 1(11β-HSD1) amplifies intracellular GC signaling with 11β-HSD1KO mice protected from the side-effects of GC excess. Brown adipose tissue (BAT) function is impaired by GC’s, which repress UCP1 and beta-adrenergic stimulated thermogenesis. Identifying mechanisms regulating BAT function is important a...

ea0041oc9.3 | Endocrine Tumours | ECE2016

Stressed to death – antioxidant pathway targeting as a novel therapeutic approach in adrenocortical carcinoma

Chortis Vasileios , Taylor Angela E , Doig Craig L , Meimaridou Eirini , Metherell Louise A , Arlt Wiebke , Foster Paul A

Context: Nicotinamide nucleotide transhydrogenase (NNT) is a NADPH-generating mitochondrial proton pump with a central role in mitochondrial antioxidant pathways. Recent studies revealed inactivating NNT mutations in patients with familial glucocorticoid deficiency, indicating a selective susceptibility of the adrenal cortex to NNT deficiency and oxidative stress. Here we explored the potential value of NNT as a therapeutic target in adrenocortical cancer.<p class="abstext...

ea0038p145 | Neoplasia, cancer and late effects | SFEBES2015

Nicotinamide nucleotide transhydrogenase (NNT) as a novel molecular target in adrenocortical carcinoma – impact of NNT knockdown on adrenocortical cell proliferation, redox balance and steroidogenesis

Chortis Vasileios , Taylor Angela , Doig Craig , Meimaridou Eirini , Metherell Lou , Arlt Wiebke , Foster Paul

Nicotinamide nucleotide transhydrogenase (NNT) is a NADPH-generating mitochondrial proton pump with a central role in mitochondrial antioxidant pathways. Recent studies revealed inactivating NNT mutations in patients with familial glucocorticoid deficiency, indicating a selective susceptibility of the adrenal cortex to NNT deficiency and oxidative stress. Here we explored the potential value of NNT as a therapeutic target in adrenocortical cancer. We delineated the distinct ef...

ea0037ep389 | Diabetes (pathiophysiology &amp; epitemiology) | ECE2015

Increasing NAD+ availability in skeletal muscle to augment energy metabolism

Fletcher Rachel , Doig Craig , Zielinska Agnieszka , Griffin Aliesha , Philp Andrew , Lavery Gareth

NAD+, an essential coenzyme in energy production, has recently risen to prominence as a signalling molecule central in mediating cellular metabolism and mitochondrial function. NAD+ dependent protein deacetylase sirtuin (SIRT) proteins regulate key metabolic transcription factors, including FOXOs and PGC-1α in muscle, in response to cellular energy demands and metabolic stress. Declining NAD+, metabolic and mitochondrial function are hallm...